JUN 27, 2018 6:51 AM PDT

Potential Drug May 'Freeze' Cancer Cells

WRITTEN BY: Nouran Amin

New research study is bringing hope to cancer patients undergoing the early stages of the disease, published in the journal Nature Communications, the study examines a drug compound that can put a stop onto cancer motility.

When cancer cells spread to other regions of our body that is known as metastasis which is a hallmark for deciding a cancer patient's death.

“For the vast majority of cancer—breast, prostate, lung, colon, and others—if it is detected early when it is a little lump in that organ and it has not spread, you will live. And generally, if you find it late, after it has spread throughout your body, you will die,” explains study author, Raymond Bergan, “Movement is key: the difference is black and white, night and day. If cancer cells spread throughout your body, they will take your life. We can treat it, but it will take your life.”

Although awareness on cancer is high, research was only able to focus on therapies that can kill cancer cells with no current treatment known.

However, in 2011, Bergan and colleagues began a study with chemists to seek a drug that would primarily inhibit cancer motility. They found a compound known as KBU2046 that has the potential ability to exert effects on cell motility in multiple cancers.

The study was achieved by utilizing chemical synthesis approaches to identify compounds that could alter motility in tumor cells without debilitating side effects or toxicity.

“We started off with a chemical that stopped cells from moving, then we increasingly refined that chemical until it did a perfect job of stopping the cells with no side effects,” Bergan explained.

The goal for this drug is to ultimately mange cancer in the early stages before reaching the incurable phase. However, the study has yet to expand in human testing.

“Our eventual goal is to be able to say to a woman with breast cancer: here, take this pill and your cancer won’t spread throughout your body. The same thing for patients with prostate, lung, and colon cancer,” explains Bergan.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 17, 2020
Cannabis Sciences
APR 17, 2020
Does CBD Really Ease Arthritis Pain?
Cannabis products are increasingly used to treat chronic pain from arthritis. As its non psychoactive ingredient, cannab ...
APR 23, 2020
Cancer
APR 23, 2020
Doctors, watch out for unexpected side effects in small clinical trials
Doctors who have patients in small-sized clinical trials that test new cancer drugs should be on the look-out for unexpe ...
APR 17, 2020
Drug Discovery & Development
APR 17, 2020
Overcoming Multi-Drug Resistance in Cancer
Resistance to chemotherapeutic use in caner patients is something that is inevitable. Continued resistance to these drug ...
APR 30, 2020
Cancer
APR 30, 2020
A New microRNA for the Cancer Fighting Toolkit
MiRNAs are small snippets of genetic information that regulate gene expression thought to be able to regulate up to 60% ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 26, 2020
Drug Discovery & Development
MAY 26, 2020
Eliminating Drug Side-Effects
Can we live in a world that completely eliminates side-effects from therapeutics? Well, scientists from Hong Kong Baptis ...
Loading Comments...